Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1798241

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1798241

Sarcopenia Treatment

PUBLISHED:
PAGES: 277 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Sarcopenia Treatment Market to Reach US$3.6 Billion by 2030

The global market for Sarcopenia Treatment estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Vitamin D & Calcium Supplements, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Protein Supplements segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$811.8 Million While China is Forecast to Grow at 6.2% CAGR

The Sarcopenia Treatment market in the U.S. is estimated at US$811.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$718.5 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Sarcopenia Treatment Market - Key Trends & Drivers Summarized

Why Is Sarcopenia Emerging as a Critical Target for Therapeutic Innovation in Aging Populations?

Sarcopenia, characterized by progressive skeletal muscle loss and functional impairment, is rapidly gaining attention as a standalone clinical entity rather than just a byproduct of aging. With growing awareness about frailty-related hospitalization risks, mobility decline, and the economic burden of elderly care, healthcare systems are increasingly prioritizing early detection and treatment of sarcopenia. The condition has been officially recognized by the ICD-10 coding system and is now included in geriatric risk assessments across the U.S., Europe, and Japan. This regulatory recognition is catalyzing clinical research, diagnostic development, and therapeutic intervention strategies tailored to sarcopenia’s unique pathophysiology.

Current treatment approaches are moving beyond nutritional supplementation and physical rehabilitation to include pharmacological agents that target muscle anabolism and mitochondrial function. Investigational therapies such as selective androgen receptor modulators (SARMs), myostatin inhibitors, and mitochondrial enhancers are under various stages of clinical evaluation. These candidates aim to promote muscle protein synthesis, reduce catabolism, and improve mitochondrial efficiency-all of which contribute to reversing or slowing the progression of sarcopenia. Moreover, several biotech startups are leveraging RNA-targeted platforms and metabolic modulators to develop first-in-class sarcopenia-specific drugs, reflecting a growing investor and research interest in this under-addressed condition.

How Are Diagnostic and Patient Stratification Advances Shaping Therapeutic Development?

The evolution of diagnostic modalities is significantly enhancing the precision and scope of sarcopenia treatment. Dual-energy X-ray absorptiometry (DXA), bioelectrical impedance analysis (BIA), and computed tomography (CT) scans are now being used not only for muscle mass quantification but also for longitudinal monitoring of therapy outcomes. Digital muscle function trackers and gait analysis tools are being integrated into clinical trials to generate more granular, real-world evidence on treatment efficacy. These diagnostics are enabling personalized treatment regimens, particularly in frail elderly populations with multiple comorbidities where a one-size-fits-all approach is ineffective.

Patient stratification based on inflammatory biomarkers, hormonal imbalances, and metabolic risk profiles is becoming integral to trial design and clinical practice. Chronic low-grade inflammation, insulin resistance, and deficiencies in testosterone or vitamin D are now recognized as key risk amplifiers of sarcopenia. Consequently, treatment approaches are being tailored to specific patient phenotypes-such as inflammatory sarcopenia or cachexia-linked muscle wasting in cancer patients. These advances are allowing pharmaceutical companies and research institutions to recruit more targeted patient cohorts and design mechanism-specific interventions, accelerating regulatory pathways and improving clinical success rates.

What Therapeutic Approaches Are Being Explored to Address This Multifactorial Condition?

The therapeutic pipeline for sarcopenia is expanding beyond basic muscle enhancement to include multifaceted strategies addressing neuromuscular coordination, metabolic regulation, and hormonal support. SARMs such as enobosarm (GTx-024) and MK-0773 have demonstrated promising anabolic effects in early trials, while myostatin pathway inhibitors like bimagrumab and anti-activin receptor antibodies are being tested for their ability to block muscle degradation signals. Additionally, metabolic agents such as metformin and mitochondrial biogenesis boosters are under investigation for their indirect benefits on muscle mass and strength.

Nutraceuticals and combination therapies are also gaining clinical traction. Formulations combining high-leucine whey protein, omega-3 fatty acids, and vitamin D are being evaluated in long-term studies to determine synergistic benefits. These combinations are particularly relevant in post-hospital recovery settings and among older adults with low dietary protein intake. Furthermore, neuromuscular electrical stimulation (NMES) devices and robotic rehabilitation systems are being introduced in sarcopenia care to augment physical therapy in patients with limited mobility. These hardware-based interventions are being paired with digital tracking apps to record performance, guide therapy adjustments, and ensure compliance.

What Factors Are Accelerating the Global Growth of Sarcopenia Treatment Options?

The growth in the sarcopenia treatment market is driven by several factors, including the rapidly aging global population, increased clinical recognition of sarcopenia as a disease, and the shift toward preventive geriatrics. As life expectancy rises, sarcopenia-related disability is emerging as a leading contributor to age-related health expenditures, particularly in countries like Japan, Italy, Germany, and South Korea. Health insurers and policy makers are supporting early intervention strategies by funding screening programs, nutritional subsidies, and rehab services, which in turn create downstream demand for pharmacological and supportive care treatments.

Additionally, clinical trials are gaining momentum, with more than 100 studies registered globally targeting muscle wasting and sarcopenia-related endpoints. Biopharma companies are forming strategic collaborations with academic centers and aging research institutes to accelerate drug discovery and expand the knowledge base. Regulatory bodies like the FDA and EMA have expressed willingness to consider surrogate endpoints such as gait speed and grip strength, which can shorten trial durations and facilitate faster approvals. Moreover, the availability of companion diagnostics and digital biomarkers is enhancing trial precision and post-market monitoring.

Growing public awareness, wearable technology adoption, and demand for aging-in-place solutions are further propelling this market. The convergence of biotechnology, diagnostics, and rehabilitation systems is laying the foundation for comprehensive sarcopenia management programs across care settings. As health systems evolve to meet the demands of an aging population, the sarcopenia treatment market is poised to see accelerated investment, clinical adoption, and commercial expansion worldwide.

SCOPE OF STUDY:

The report analyzes the Sarcopenia Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements, Other Treatment Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Biophytis SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Endo International plc
  • GlaxoSmithKline plc
  • Hologic Inc.
  • Merck & Co., Inc.
  • MyoDyna AS
  • Novartis AG
  • Pfizer Inc.
  • Radius Health Inc.
  • Regeneron Pharmaceuticals
  • Sanofi
  • SARCO Biosystems Inc.
  • TSI Group Ltd.
  • Veru Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP39303

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sarcopenia Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Age-Related Muscle Loss Throws the Spotlight on Sarcopenia Treatment Market
    • Growth in Aging Global Population Propels Demand for Therapeutic and Preventive Interventions
    • Expansion of Geriatric Wellness and Frailty Clinics Drives Interest in Sarcopenia Treatment Pathways
    • Integration of Resistance Training With Nutritional Supplementation Strengthens Treatment Outcomes
    • Increased R&D in Myostatin Inhibitors and Anabolic Therapies Spurs Innovation in Drug Pipelines
    • Regulatory Recognition of Sarcopenia as a Disease Category Expands Scope for Clinical Trials
    • Growing Demand for Functional Mobility and Quality of Life Metrics Drives Personalized Therapies
    • Advancements in Muscle Mass Assessment Techniques Boost Early Diagnosis and Intervention Rates
    • Rising Use of Amino Acid-Based Supplements Accelerates Adoption in Community Health Programs
    • Pharma Partnerships With Academic Institutions Fuel Biomarker Discovery and Target Validation
    • Increased Awareness Among Primary Care Physicians Spurs Early Identification and Treatment Referrals
    • Use of Digital Health Platforms and Wearables Enhances Patient Monitoring and Treatment Adherence
    • Expansion of Gait and Strength Assessment Tools Propels Reimbursement for Sarcopenia Screening
    • OEM Innovation in Exoskeletons and Assistive Mobility Devices Enhances Non-Pharmaceutical Interventions
    • Shift Toward Multidisciplinary Treatment Approaches Strengthens Role of Physiotherapy in Sarcopenia Care
    • Growing Evidence Linking Sarcopenia With Chronic Diseases Drives Inclusion in Comorbidity Management
    • Rise of Nutraceutical and Functional Food Products Targets Muscle Health in Aging Populations
    • Launch of Combination Therapies and Dual-Mechanism Agents Expands Clinical Efficacy Options
    • Health Insurance Reforms and Aging-In-Place Programs Propel Access to Sarcopenia Treatments
    • Clinical Validation of Testosterone Modulators and SARMs Creates New Therapeutic Pathways
    • Growing Adoption of Tele-Rehabilitation Models Sustains Remote Engagement in Muscle Maintenance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sarcopenia Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sarcopenia Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Vitamin D & Calcium Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Vitamin D & Calcium Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Vitamin D & Calcium Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Protein Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Protein Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Protein Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vitamin B12 Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vitamin B12 Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Vitamin B12 Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Sarcopenia Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Sarcopenia Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Sarcopenia Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Sarcopenia Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Sarcopenia Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • Sarcopenia Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Sarcopenia Treatment by Treatment Type - Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Sarcopenia Treatment by Treatment Type - Percentage Breakdown of Value Sales for Vitamin D & Calcium Supplements, Protein Supplements, Vitamin B12 Supplements and Other Treatment Types for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Sarcopenia Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Sarcopenia Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!